Please assess the completion status of the following clinical trial:

Trial Title: Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pain: pain will be assessed as the physician touches lateral epicondyle or passively flexing the patient's wrist and while the patient extends his/her wrist or 3rd finger against resistance. Individuals who fulfill two or more of above will be considered to have lateral epicondylitis.~* Symptom duration: should be at least 6 months.~* Previous trial of complete course of physiotherapy and corticosteroid injection.~Exclusion Criteria:~* Rheumatoid arthritis~* Generalized polyarthritis~* Local elbow arthritis~* Simultaneous medial epicondylalgia~* Bilateral lateral epicondylitis~* Neurologic deficits (abnormal light touch sensation, deep tendon reflexes abnormality, radicular pain, radial nerve entrapment, signs of nerve root compression, decreased muscle force, multiple sclerosis, seizures)~* The use of corticosteroid in last 30 days~* Simultaneous use of drugs other than acetaminophen or physical therapy in the course of study~* Pregnancy~* Breast-feeding~* Previous hand surgery~* Having a hobby or job that needs finger extension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): None
- B (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).